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ABSTRACT
Objectives: Escherichia coli is a Gram-negative rod (bacillus) in the family Enterobacteriaceae. In general, it is harmless, but some special species 
could cause harmful infection. In the recent era, the number of antibiotics is available to combat infection caused by E. coli but because of resistance 
developed against available antibiotics research is continuously going on to synthesize newer antibiotic to overcome this problem. Synthesis and 
screening of benzothiazole derivatives have great importance in heterocyclic chemistry because of its potent and significant biological activities 
against E. coli especially methoxy substitution at benzothiazole.
Methods: Methoxy substituted benzothiazole derivatives were synthesized by reaction of 3- chloro-4-methoxy-aniline with potassium thiocyanate 
under temperature control and presence of bromine in glacial acetic acid and ammonia. Substituted nitrobenzamides then synthesized by condensation 
of 2-amino-4-chloro-5-methoxy-benzothiazole with 2 (3 or 4)-nitrobenzoyl chloride acid in the presence of dry pyridine and acetone. Finally, newly 
synthesized derivatives (K-01 to K-09) were synthesized through replacing of chlorine of nitrobenzamide by reaction with 2-nitroaniline, 3-nitroaniline, and 
4-nitroaniline in the presence of dimethoxy formamide. Analytical characterization was performed by thin-layer chromatography, melting point, infrared, 
and nuclear magnetic resonance. Antibacterial activity was performed against E. coli by cup plate method (diffusion technique) using streptomycin as 
standard. Compound K-03 showed potent antibacterial activity against E. coli at both concentrations 50 µg/mL and 100 µg/mL as compared to standard.
Results: Compound D-03 exhibited excellent activity among all synthesized compounds.
Conclusion: In the present work, efforts have been made to synthesized methoxy substituted benzothiazole derivatives and screened for antibacterial 
activity. Compound K-03 found as most active against E. coli.
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INTRODUCTION
Escherichia coli is a Gram-negative rod (bacillus) in the family 
Enterobacteriaceae. Most E. coli is normal commensals found in the 
intestinal tract. Pathogenic strains of this organism are distinguished 
from normal flora by their possession of virulence factors such as 
exotoxins [1-3]. Pathogenic E. coli can be classified into pathotypes 
by their virulence factors, together with the type of disease. The six 
pathotypes capable of producing gastrointestinal disease in humans 
are enteropathogenic E. coli, enterotoxigenic E. coli, enteroaggregative 
E. coli, enteroinvasive E. coli, diffusely adherent E. coli, and 
enterohemorrhagic E. coli [4-7]. Most strains of these bacteria are 
harmless but a specific strain of E. coli that causes illness. It was first 
recognized as a cause of illness during an outbreak of hemorrhagic 
colitis (severe bloody diarrhea) in 1982 since anyone can become 
infected with E. coli. The elderly and children under 5 years of age 
are at greatest risk of developing a serious illness [8]. In the recent 
era, the number of antibiotics is available to combat infection caused 
by E. coli, but because of resistance developed against available 
antibiotics research is continuously going on to synthesize newer 
antibiotic to overcome this problem. Benzothiazole is a therapeutically 
important privileged bicyclic ring system contains sulfur and 
nitrogen as a heteroatom. Synthesis and screening of benzothiazole 
derivatives have great importance in heterocyclic chemistry because 
of its potent and significant biological activities. Substitution at C-2 
of benzothiazole nucleus has emerged in its usage as a core structure 
in the diversified therapeutically applications [9-13]. As per reported 
biological activities of benzothiazole derivatives, it was found that 
change of the structure of substituent group at benzothiazole nucleus 
commonly results in the change of its bioactivities. Commonly change 
of substitution at C-2 benzothiazole nucleus especially with aryl-nitro 
has already been proven its therapeutic importance. Till date, various 
biological activities for benzothiazole derivatives have been reported 
as antitumor, antitubercular, antimalarial, anticonvulsant, anthelmintic, 
analgesic, anti-inflammatory, antibacterial and antifungal, a topical 
carbonic anhydrase inhibitor, and an antihypoxic [14-17]. 2-substituted 
benzothiazole derivatives were first discovered in 1887 by A. W. 
Hofmann as simple cyclization mechanism and number of the synthetic 
scheme has been reported. The most common and classical method 
were reported as direct method that involved condensation of an ortho-
aminothiophenol with a substituted aromatic aldehyde, carboxylic acid, 
acyl chloride or nitrile to synthesize C-2 substituted benzothiazoles, 
but it was found that this method is not appropriate for majority 
of substituted C-2 aryl benzothiazoles because the main difficulty 
encountered in synthesis of the readily oxidisable 2-aminothiophenols 
bearing substituent groups. For the above-said reason, some other 
methods were reported and extensively used in the laboratories that 
based on the use of the potassium ferricyanide radical cyclization 
of thiobenzanilides [18]. This method was named as Jacobsen 
cyclization and popularized because it produced only one product. As 
per reported method, it involved cyclization onto either carbon atom 
ortho to the anilido nitrogen. Due to selective product synthesis, the 
Jacobsen cyclization was considered as a highly effective strategy for 
benzothiazole synthesis, for example, for the synthesis of substituted 
benzothiazoles, radical cyclization of the 3-fluoro- or 3,4-difluoro-
substituted thiobenzanilides [19-28]. The present work concern with 
the synthesis of methoxy and aryl-nitro substituted benzothiazole 
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derivatives followed by the antibacterial activity for a structure-activity 
relationship.
METHODS
Synthesis of substituted benzothiazole (Compound Code 1-KB)
Synthesis of substituted benzothiazole nucleus was achieved by adding 
8 g (0.08 mol) of potassium thiocyanate, and 1.45 g (0.01 mol) of 
3-choloro-4-methoxy-aniline into 20 mL cooled glacial acetic acid in 
such a way that the temperature not exceeded above room temperature. 
Freezing mixture of ice and salt was used to control the temperature of 
reaction with continuous mechanical stirring. Again temperature control 
was maintained during the addition of a solution of 1.6 mL of bromine in 
6 mL of glacial acetic acid using dropping funnel. The time of addition of 
bromine also considered to take around 105 min to control temperature. 
During the addition of bromine, the temperature was controlled to never 
rise beyond the room. As the addition of bromine was completed the 
solution stirred for 2 h but below room temperature. After that solution 
was again stirred at room temperature for 10 h and allowed to stand 
overnight to get precipitate followed by heating at 85°C on a steam 
bath after addition of 6 mL water and filtered hot (Filtrate-01). In the 
resulting precipitate, 10 mL of glacial acetic acid was added and heated 
with at 85°C and filtered hot (Filtrate-02). Finally, both filtrate combined 
and cooled at room temperature followed by neutralization with 
concentrated ammonia solution to pH-6 to get precipitate. The resulting 
product treated with animal charcoal and recrystallized from benzene, 
ethanol of 1:1 to get substituted benzothiazole.
Synthesis of nitrobenzamide (Compound code 2-KB, 3-KB, and 4-KB)
5.36 g (0.026 mol) of 2-(3 or 4)-nitrobenzoyl chloride was dissolved 
in dry acetone. Product 1-KB separately dissolved in dry pyridine and 
added dropwise into the solution of 2-(3 or 4)-nitrobenzoyl chloride 
with continuous stirring at room temperature. After complete addition 
stirring was continued for another 30 min then transferred into 200 mL 
ice cold water. Finally, recrystallized with ethanol to get intermediate 
nitrobenzamide compound 2-KB, 3-KB, and 4-KB.
Synthesis of compound K-01 to K-09
0.008 mol of 2 (3 or 4) nitro-substituted aniline was refluxed with 2.7 g 
(0.0075 mol) of compound 2-KB, 3-KB, and 4-KB separately for 2 h 
in the presence of dimethoxy formamide (DMF). After 2 h reflux, the 
mixture cooled at room temperature and poured into crushed ice. The 
solid was separated, dried, and recrystallized with super dry alcohol to 
get novel benzothiazole derivatives K-01 to K-09 (Fig. 1).
Analytical characterization
Thin layer chromatography (TLC) was used to monitor reaction 
progress, completion and identification of newly synthesized 
compounds from starting material using solvent system butanol: ethyl 
acetate: benzene [1:2:1] and detection performed by exposing them to 
iodine vapors. The melting point of compounds was determined using 
the open capillaries method. Structure elucidation of compounds was 
done by IR and 1HNMR spectral study. SHIMADZU (8400S) used for IR 
spectral study (KBr pellet technique). For the structure elucidation using 
IR, frequency range for Ar-C=C, C=O, C-S, and C-NO2 was considered. 
Bruker AM 400 1HNMR instrument (at 400 MHz) was used using 
CDCL3 as a solvent and tetramethoxysilane as an internal standard. 
For structure elucidation by 1HNMR, NH proton that characterized 
benzothiazole was considered.
Antibacterial activity against E. coli
The standard drug and synthesized compounds were dissolved in 
minimum quantity of DMF and adjusted and made up the volume 
with distilled water to get 50 µg/mL and 100 µg/mL concentrations. 
The antibacterial activity was performed by the cup plate method 
(diffusion technique). The fresh culture of bacteria was obtained by 
inoculating bacteria into peptone water liquid media and incubated 
at 37±2°C for 18–24 h. This culture mixed with nutrient agar media 
(20%) and poured into Petri dishes by following aseptic techniques. 
After solidification of the media, five bores were made at an equal 
distance using sterile steel cork borer (8 mm diameter). Into these 
cups, different concentrations of standard drug and synthesized 
compounds were introduced. DMF was used as a control. After the 
introduction of standard drug and synthesized compounds, the 
plates were placed in a refrigerator at 8.0–10°C for proper diffusion 
of drugs into the media. After 2 h of cold incubation, the Petri plates 
are transferred to the incubator and maintained at 37±2°C for 18–24 h. 
After the incubation period, the Petri plates were observed for the zone 
of inhibition using a Vernier scale. The results evaluated by comparing 
the zone of inhibition shown by the synthesized compounds with the 
standard drug. The results are the mean value of the zone of inhibition 
measured in millimeter of two sets.
Fig. 1: Synthetic scheme
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RESULTS AND DISCUSSION
Benzothiazole contains sulfur and nitrogen as heteroatom but imparts 
biological activity while substitution at the C-2 position. In the present 
work, methoxy substituted benzothiazole nucleus while 2-(3 or 4)-
aryl nitro considered as rotating substitution at C-2 and C-4 position 
of benzothiazole nucleus derivatives were synthesized. The novel 
derivatives (K-01 to K-09) evaluated for antibacterial activity against 
E. coli. In the present work, nitro group considers as rotating basis 
on ortho, meta, and para position. The reason behind considering the 
nitro group as a substituent is the fungi rarely acquire resistance. TLC, 
melting point, IR, and 1HNMR were used for analytical characterization. 
In the TLC, the distance traveled by compound K-01 to K-09 was 
found to be different from that of the starting compound that proved 
synthesized compounds were different from parent one, even during 
TLC performance every time single spot was obtained; hence, it also 
reveals that synthesized compounds were free from impurity as well 
as reaction was completed. Structure elucidation by IR spectroscopy 
frequency range for Ar C=C, C=O, C-S, and C-NO2 was considered. In 
case of structure elucidation of by 1HNMR sharp characteristic signal 
at 7.0–8.0 ppm is observed and consider as benzothiazole in all the 
synthesized compounds (Table 1). Antibacterial activity performed 
at two concentration 50 µg/mL and 100 µg/mL using streptomycin 
as a standard drug against E. coli. Compound K-03 showed potent 
antibacterial activity against E. coli at both concentrations 50 µg/mL 
and 100 µg/mL as compared to standard (Table 2 and Fig. 2). The 
structure-activity relationship of newly synthesized compound 
revealed that 2-aryl nitro at C-2 and 4-aryl nitro at the C-4 position 
of methoxy-substituted benzothiazole derivative (Compound K-03) 
exhibited prominent inhibitory activity against E. coli.
CONCLUSION
In the present work, methoxy substituted novel benzothiazole derivatives 
were synthesized and screened for antibacterial activity against E. coli. 
The paucity of data showed that compound K-03 showed potent activity 
and could be considered for further clinical trials as antibacterial agents.
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Fig. 2: Result of the zone of inhibition of synthesized compounds
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